CardioMEMS HF System
ABBOTT MEDICAL · Decision date Jan 9, 2026
What did the FDA approve?
FDA records P100045/S082 as a supplement to PMA P100045, with the supplement type “135 Review Track For 30-Day Notice”. The recorded decision is approval, dated Jan 9, 2026.
FDA approval order statement
implementation of a Delivery System Coating Supplier Process Change for use in the manufacturing of the CardioMEMS PA Sensor and Delivery System
- Regulatory pathway
- PMA supplement
- Supplement type
- 135 Review Track For 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Jan 9, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P100045/S082
- Regulatory pathway
- PMA supplement
- Applicant
- ABBOTT MEDICAL
- Product code
- MOM
- Decision code
- APPR
- Decision date
- Jan 9, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: System, hemodynamic, implantable.
- Applicant
- Abbott Medical
- Product code
- MOM
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P100045. Subsequent supplements may change the device or its indications.
FDA decision timeline
P100045 · Original PMA
CARDIOMEMS HF PRESSURE MEASUREMENT SYSTEM
P100045/S082 received
Application receipt date recorded by FDA.
P100045/S083 · Related supplement
CardioMEMS HF System
P100045/S084 · Related supplement
CardioMEMSTM HF System
P100045/S085 · Related supplement
CARDIOMEMS HF PRESSURE MEASUREMENT SYSTEM
P100045/S079 · Related supplement
CardioMEMS HF System
P100045/S087 · Related supplement
CardioMEMS HF System (Merlin.net PCN HF Portal (Model MN6000) and CardioMEMS Backend Web Application (Model CM4000))
P100045/S082 · FDA decision
135 Review Track For 30-Day Notice
P100045/S086 · Related supplement
Next Gen Patient System CM1200 CardioMEMS HERO Device
P100045/S088 · Related supplement
CardioMEMS HF System
P100045/S089 · Related supplement
CardioMEMS HF System
P100045/S090 · Related supplement
CardioMEMS HF System
P100045/S092 · Related supplement
CardioMEMS PA Sensor and Delivery System (CM2000); CardioMEMS HF System
P100045/S091 · Related supplement
CardioMEMS HF System; Merlin.net PCN HF Portal (Model MN6000); CardioMEMS Backend Web Application (Model CM4000); HF Clo
P100045/S093 · Related supplement
CardioMEMS PA Sensor and Delivery System
Timeline entries are records held by MedtechLedger for P100045. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P100045
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| ABBOTT MEDICAL | PMA approval | May 28, 2014 | FDA | |
CardioMEMS HF SystemP100045/S083 | ABBOTT MEDICAL | PMA supplement | Jul 28, 2025 | FDA |
CardioMEMSTM HF SystemP100045/S084 | ABBOTT MEDICAL | PMA supplement | Sep 10, 2025 | FDA |
CARDIOMEMS HF PRESSURE MEASUREMENT SYSTEMP100045/S085 | ABBOTT MEDICAL | PMA supplement | Sep 17, 2025 | FDA |
CardioMEMS HF SystemP100045/S079 | ABBOTT MEDICAL | PMA supplement | Sep 24, 2025 | FDA |
| ABBOTT MEDICAL | PMA supplement | Nov 10, 2025 | FDA | |
| ABBOTT MEDICAL | PMA supplement | Feb 27, 2026 | FDA | |
CardioMEMS HF SystemP100045/S088 | ABBOTT MEDICAL | PMA supplement | Mar 25, 2026 | FDA |
CardioMEMS HF SystemP100045/S089 | ABBOTT MEDICAL | PMA supplement | May 13, 2026 | FDA |
CardioMEMS HF SystemP100045/S090 | ABBOTT MEDICAL | PMA supplement | Jun 1, 2026 | FDA |
| ABBOTT MEDICAL | PMA supplement | Sep 11, 2026 | FDA | |
| ABBOTT MEDICAL | PMA supplement | Sep 30, 2026 | FDA | |
CardioMEMS PA Sensor and Delivery SystemP100045/S093 | ABBOTT MEDICAL | PMA supplement | Sep 30, 2026 | FDA |
Explore the linked device profile
Other records with product code MOM
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Cordella Pulmonary Artery Sensor SystemP230040/S030 | Endotronix, Inc. | PMA supplement | Oct 29, 2026 | FDA |
| Endotronix, Inc. | PMA supplement | Oct 20, 2026 | FDA | |
| Endotronix, Inc. | PMA supplement | Oct 16, 2026 | FDA | |
| Endotronix, Inc. | PMA supplement | Oct 14, 2026 | FDA | |
| Endotronix, Inc. | PMA supplement | Sep 25, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Abbott Medical
- Headquarters
- Not reported
- Brand website
- abbott.com
- FDA applicant address
- 387 Nerem St. NW, Suite #500, Atlanta, GA, 30313
Sources and methodology
- Original FDA record: P100045/S082
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records






